Where I see patients (4)
Selected research
-
Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP).
Future oncology (London, England)
-
Prostate-specific membrane antigen positron emission tomography/computed tomography imaging as a precision diagnostic at prostate cancer recurrence after radical prostatectomy: Modeling long-term survival.
Cancer
-
Utility of metastasis-directed radiotherapy with and without hormonal therapy in management of oligometastatic prostate cancer.
JNCI cancer spectrum